While the reduction in price target could suggest a slightly less optimistic outlook on Amdocs' future stock price performance, the maintenance of a Buy rating indicates Citigroup's continued positive view on the company's fundamentals. This mixed signal might lead to a neutral short-term impact on Amdocs' stock price as investors weigh the lowered price target against the sustained Buy rating.